All data are based on the daily closing price as of November 20, 2026
s

Samsung Biologics

207940.KO
1013.96 USD
-20.26
-1.96%

Overview

Last close
1013.96 usd
Market cap
49.19B usd
52 week high
1154.38 usd
52 week low
655.09 usd
Target price
742.91 usd

Valuation

P/E
36.0675
Forward P/E
33.2226
Price/Sales
12.8349
Price/Book Value
7.6762
Enterprise Value
48.58B usd
EV/Revenue
13.3276
EV/EBITDA
22.7997

Key financials

Revenue TTM
3.80B usd
Gross Profit TTM
2.06B usd
EBITDA TTM
2.10B usd
Earnings per Share
28.32 usd
Dividend
N/A usd
Total assets
9.36B usd
Net debt
N/A usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
  • Symbol
    207940.KO
  • Exchange
    KO
  • Isin
    KR7207940008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Mr. John Chongbo Rim
  • Headquarter
    Incheon
  • Web site
    https://samsungbiologics.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top